Canada sets up Ottawa research hub to boost vaccine production

Innovation, Science and Economic Development Canada

This research hub will further strengthen Canada's biomanufacturing and life sciences sector while protecting Canadians against future health threats

The Government of Canada's main priority continues to be protecting the health and safety of Canadians. Throughout the pandemic, the quick and decisive actions taken by the government meant that Canada was able to scale up domestic biomanufacturing capacity, which had been in decline for over 40 years. The government is rebuilding a strong and competitive biomanufacturing and life sciences sector brick by brick. This includes strengthening the foundations of the life sciences ecosystem through the research and talent of Canada's world-class post-secondary institutions and research hospitals, as well as fostering increased collaboration with innovative companies.

Today, the Honourable Mona Fortier, President of the Treasury Board, highlighted an investment of $2 million to create the Canadian Pandemic Preparedness Hub. This support is part of a $10 million investment announced by the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and the Honourable Jean-Yves Duclos, Minister of Health, on March 2 for the creation of five research hubs as part of Stage 1 of the integrated Canada Biomedical Research Fund (CBRF) and Biosciences Research Infrastructure Fund (BRIF) competition.

The Canadian Pandemic Preparedness Hub is being led by the University of Ottawa and McMaster University. It will catalyze research and biomanufacturing innovations to help Canada produce vaccines, therapeutics and diagnostics ahead of future pandemics. This multidisciplinary research hub will accelerate research and development of next-generation vaccines, therapeutics and diagnostics, while supporting training and development to expand the pipeline of skilled talent. It will also accelerate the translation of promising research into commercially viable products and processes.

This investment will help strengthen the resilience of Canada's life sciences sector by supporting leading Canadian research in innovative technologies that keep us safe and boost our economy.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.